PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFlax seed
Flax seed
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
160 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352—H04.12———123
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cardiovascular diseasesD002318EFO_0000319I98131—812
InflammationD007249MP_0001845—231—712
Metabolic syndromeD024821EFO_0000195E88.810—33—610
Type 2 diabetes mellitusD003924EFO_0001360E11—21—79
SyndromeD013577——132—59
HypercholesterolemiaD006937——143—28
Diabetes mellitusD003920EFO_0000400E08-E13—11—67
HypertensionD006973EFO_0000537I10—21—57
OverweightD050177—E66.3111—57
Breast neoplasmsD001943EFO_0003869C50—21—25
Show 14 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9—1——1516
Polycystic ovary syndromeD011085EFO_0000660E28.211——24
Oxidative stressD018384EFO_1001905—22——14
Morbid obesityD009767EFO_0001074——1——12
PainD010146EFO_0003843R5212———2
AgingD000375GO_0007568R41.8112———2
Prostatic neoplasmsD011471—C61—1——12
FibrosisD005355——11———2
Cystic fibrosisD003550EFO_0000390E8411———2
AtherosclerosisD050197EFO_0003914I25.1—1——12
Show 11 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2———68
HyperglycemiaD006943—R73.91———12
Ovarian neoplasmsD010051EFO_0003893C561————1
Fallopian tube neoplasmsD005185——1————1
Ovarian epithelial carcinomaD000077216——1————1
Non-small-cell lung carcinomaD002289——1————1
Radiation effectsD011830——1————1
PoisoningD011041EFO_0008546T65.911————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Insulin resistanceD007333EFO_0002614E88.819————66
Metabolic diseasesD008659EFO_0000589E88.9————55
Healthy dietD000072001——————44
HyperlipidemiasD006949EFO_0003774E78.5————33
Prediabetic stateD011236EFO_1001121R73.03————33
Lipid metabolism disordersD052439——————33
HypertriglyceridemiaD015228EFO_0004211—————22
Keratoconjunctivitis siccaD007638EFO_1000906—————22
Coronary diseaseD003327——————22
Coronary artery diseaseD003324—I25.1————22
Show 59 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
74 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use